Jeremy Hirota, a St. Joseph’s Healthcare-Hamilton researcher, has been awarded a New Investigator Research Grant to help create a precision medicine…
Patrícia Silva, PhD
Patrícia holds a PhD in medical microbiology and infectious diseases from the Leiden University Medical Center, Netherlands, and completed a postdoctoral research fellowship at the Instituto de Medicina Molecular, Lisbon, Portugal. Her work in academia was mainly focused on molecular biology and the genetic traits of infectious agents such as viruses and parasites. Patrícia earned several travel awards to present her work at international scientific meetings. She is a published author of several peer-reviewed science articles.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Patrícia Silva, PhD
The Colton Underwood Legacy Foundation has partnered with International Biophysics, the manufacturer of AffloVest, to provide 50…
The Cystic Fibrosis Foundation Therapeutics (CFFT) has given an award worth up to $5 million to Savara Pharmaceuticals to support the…
Galapagos has initiated a Phase 1 clinical trial in healthy volunteers to evaluate a new C2 corrector, called GLPG3221,…
Proteostasis Therapeutics is eliminating 13 research positions in order to save $3 million as it “readjusts priorities to focus…
Vertex Pharmaceuticals announced a $750,000 addition to its cystic fibrosis (CF) research innovation program that supports the work…
The 2018 spring scholarship application deadline for the United States Adult Cystic Fibrosis Association (USACFA)‘s Lauren Melissa…
People with cystic fibrosis (CF) may be able to avoid having to travel to speciality clinics if health professionals…
Cystic Fibrosis Ireland has started a “Fight to Breathe” campaign featuring a 60-second film that will be shown at 73…
Vertex Plans $500M, 10-Year Charitable Effort Spanning Aid to CF Community and Science Education
Vertex Pharmaceuticals announced the start of a $500 million, 10-year charitable commitment to cystic fibrosis (CF) and other patients using its treatments,…